1. Home
  2. NWN vs EVO Comparison

NWN vs EVO Comparison

Compare NWN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWN
  • EVO
  • Stock Information
  • Founded
  • NWN 1859
  • EVO 1993
  • Country
  • NWN United States
  • EVO Germany
  • Employees
  • NWN N/A
  • EVO N/A
  • Industry
  • NWN Oil/Gas Transmission
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWN Utilities
  • EVO Health Care
  • Exchange
  • NWN Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NWN 1.5B
  • EVO 1.6B
  • IPO Year
  • NWN N/A
  • EVO 2021
  • Fundamental
  • Price
  • NWN $39.84
  • EVO $4.44
  • Analyst Decision
  • NWN Strong Buy
  • EVO Buy
  • Analyst Count
  • NWN 2
  • EVO 2
  • Target Price
  • NWN $43.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • NWN 200.8K
  • EVO 158.8K
  • Earning Date
  • NWN 11-12-2024
  • EVO 11-06-2024
  • Dividend Yield
  • NWN 4.92%
  • EVO N/A
  • EPS Growth
  • NWN N/A
  • EVO N/A
  • EPS
  • NWN 2.06
  • EVO N/A
  • Revenue
  • NWN $1,137,832,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • NWN $0.46
  • EVO $4.56
  • Revenue Next Year
  • NWN $7.23
  • EVO $13.44
  • P/E Ratio
  • NWN $19.37
  • EVO N/A
  • Revenue Growth
  • NWN N/A
  • EVO N/A
  • 52 Week Low
  • NWN $34.82
  • EVO $2.85
  • 52 Week High
  • NWN $44.25
  • EVO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • NWN 35.06
  • EVO 45.00
  • Support Level
  • NWN $39.12
  • EVO $4.39
  • Resistance Level
  • NWN $41.83
  • EVO $4.81
  • Average True Range (ATR)
  • NWN 0.75
  • EVO 0.14
  • MACD
  • NWN -0.41
  • EVO -0.07
  • Stochastic Oscillator
  • NWN 12.36
  • EVO 0.00

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: